Entities / Company
Exagen Inc..
clinical laboratory company
- Reports this week
- 1
- Active events
- 0
- Connections
- 24
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Exagen Inc. was listed on the Nasdaq stock exchange, and Cencora was listed on the NYSE stock exchange, both on September 1, 2026.Some support2 reports
-
InfuSystems Holdings, Inc. and Exagen Inc. are small-cap healthcare companies providing services in the United States and Canada.Some support2 reports
Gone quiet
No new reports in 90+ days-
Exagen Inc. and Allurion Technologies, both small-cap medical companies, are currently being compared.Some support1 report
-
John Aballi serves as President and CEO of Exagen Inc., a medical technology company in life sciences.Some support5 reports
-
Exagen Inc. and Quanterix are companies operating in the Zacks Medical - Products industry.Some support2 reports
-
Exagen Inc. appointed Michael Mahler as Chief Scientific Officer on July 29, 2025.Some support2 reports
-
Management of Exagen Inc. will participate in conferences held in Boston on August 7, 2025.Some support1 report
-
GE HealthCare, Exagen Inc., Biogen, and Qiagen were identified as key market players in the Personalized Medicine Market.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Exagen Inc. this week
News at the entities that move Exagen Inc. most-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Exagen Inc.
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Exagen Inc.
-
Boston Shared contextThe Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Moves Exagen Inc.
Connections
The 4 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
John Aballi Structural
John Aballi serves as the President and CEO of Exagen Inc.
-
Securities and Exchange Commission Structural
Exagen Inc. is subject to regulatory oversight by the Securities and Exchange Commission through required filings.
-
Nasdaq Structural
Exagen Inc. is listed on the Nasdaq stock exchange.
-
Boston Shared context
Exagen Inc. is mentioned in connection with events and documents held in Boston, but its primary base of operations is in San Diego.
History
Events by the month they beganSeptember 2026
2 eventsJune 2026
6 events- Exagen Inc. and Allurion Technologies, both small-cap medical companies, are currently being compared.
- John Aballi serves as President and CEO of Exagen Inc., a medical technology company in life sciences.
- Exagen Inc. and Quanterix are companies operating in the Zacks Medical - Products industry.
- Exagen Inc. appointed Michael Mahler as Chief Scientific Officer on July 29, 2025.
- Management of Exagen Inc. will participate in conferences held in Boston on August 7, 2025.
- GE HealthCare, Exagen Inc., Biogen, and Qiagen were identified as key market players in the Personalized Medicine Market.